HEALTHCARE PROFESSIONALS:

For medical inquiries regarding CARDAMYST™ (etripamil) nasal spray or to request additional medical information, please call 1-877-207-4764, Option #1, or send your request to medicalinformation@milestonepharma.com

For grant submissions, such as medical education grants, investigator-initiated studies, and/or patient advocacy grants, please send your request to grants@milestonepharma.com

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

PATIENTS:

If you have a medical emergency, please call 911.  If you are experiencing symptoms of PSVT, please call your healthcare provider or call 911. For questions regarding Milestone or CARDAMYST™ (etripamil) nasal spray, please call 1-877-207-4764, Option #2, or send your request to medicalinformation@milestonepharma.com

CARDAMYST™ will be available for patients with PSVT starting early 2026. Talk to your healthcare provider about potential treatment options.